Company / Operating Income per Share
Atea Pharmaceuticals, Inc. Operating Income per Share History
FY2020-FY2022 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income per Share
-$1.57
FY2022
5-year range
-$1.57 / -$0.18
FY2020-FY2022
Trend
-787.2%
vs FY2021
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Income per Share changed -787% YoY in FY2022, a notable deviation from the 2-year average annual change of -353%.
Based on SEC 10-K filings.
-1.57 in FY2022.
Declined from $-0.94 to $-1.57 over the past 2 years.
Operating Income per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2022, operating income per share decreased 787.2% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 10.30 (safe zone, above 2.9 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Income per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2022 | -$1.57 | -787.2% |
| FY2021 | -$0.18 | +81.1% |
| FY2020 | -$0.94 | - |
As of FY2022 · SEC 10-K · Updated Jun 24, 2026